Conference Call with Dr. Lal Pathlabs Ltd. Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.
Healthcare Services company Dr. Lal Pathlabs announced Q3FY24 & 9MFY24 results: Q3FY24: Revenue: In Q3FY24, Dr Lal PathLabs reported a revenue of Rs 539 crore, marking a 10.1% increase from the Rs 489 crore recorded in Q3FY23. Operating Expenditure: The operating expenditure rose by 5.8% to Rs 398 crore in the current quarter from Rs 376 crore in the corresponding quarter of the previous fiscal year. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization): The Company's EBITDA escalated significantly by 24.6%, amounting to Rs 141 crore as compared to Rs 113 crore in Q3FY23, resulting in an EBITDA margin of 26.1%. Profit After Tax (PAT): PAT witnessed a substantial increase of 53.3% to Rs 82 crore in Q3FY24 from Rs 54 crore in Q3FY23, achieving a PAT margin of 15.3%. Earnings per Share (EPS): EPS climbed up to Rs 9.8, reflecting a remarkable 53.2% gain over the Rs 6.4 reported in Q3FY23. 9MFY24: Revenue: the Company's cumulative revenue reached Rs 1681 crore, which is a 10.2% increment year-on-year. Operating Expenditure: operating expenditure increased by 5.6% to Rs 1217 crore. EBITDA: EBITDA grew by 24.1% to Rs 465 crore, from Rs 374 crore with an improved margin of 27.6%. Profit After Tax (PAT): The nine months ended December 31, 2023, saw PAT soar by 50.5% to Rs 277 crore. Earnings per Share (EPS): EPS stood at Rs 32.9, an increase of 49.5% from the previous year. Result PDF
Healthcare Services company Dr. Lal Pathlabs announced Q2FY24 results: 1. Financial Performance - Total revenue of Rs 601 crore in Q2FY24, an increase of 12.6% compared to Q2FY23. - Revenue excluding RTPCR increased by 14.4% in Q2FY24. - EBITDA margin for Q2FY24 was 29.6%. - PBT for Q2FY24 was Rs 152 crore. - PAT for Q2FY24 was Rs 111 crore. - PAT margin for Q2FY24 was 18.4%. - The company's EPS for Q2FY24 was 13.2. 2. Operating Expenditure - Operating Expenditure for Q2FY24 was Rs 424 crore. - Operating Expenditure increased by 8.6% compared to Q2FY23. 3. Other Financial Highlights - Other Income for Q2FY24 was Rs 18 crore. - Depreciation cost for Q2FY24 was Rs 36 crore. - Finance cost for Q2FY24 was Rs 8 crore. Result PDF